Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Headache Cure is No Cure at All Not Rated 0.0 Email Routing List Email & Route  Print Print
Wednesday, September 4, 2002

Headache Cure is No Cure at All

by: Sean Hanna, Editor in Chief

One OppenheimerFunds wholesaler learned last week that creative marketing can sometimes be too creative.

The unnamed wholesaler mailed financial reps in his region a special marketing cure for "stock market headaches." Rather than curing headaches, though, he unintentionally created some more.

The firm did not reveal the identity of the wholesaler, the sales region or the consequences he faced. That wholesaler is still with the firm, though, confirmed the spokesperson.

OppenheimerFunds may be one fund firm able to keep the incident in perspective. Its headquarters had been in Two World Trade in New York. Fortunately, all of its employees successfully evacuated the building.

The mailing included aspirin tablets enclosed inside a plastic container in the envelope holding the collateral. What the wholesaler did not take into account was what happens to mail when it is sorted.

The automatic mail sorters crushed the pills creating (you guessed it) into a fine white powder.

Soon, the New York City Police Department was informed of the powder inside the envelopes. The police added the incident to their alert system through which reporters made sure word of the wholesaler's marketing efforts reached a far larger market than the intended audience of 250.

"This was an unintentional, one-time incident," said a spokesperson for OppenheimerFunds. "The pills were part of the marketing mailing that this person was sending. He did not realize the package would get crushed. As soon as we realized what the situation was we sent faxes and made phone calls to inform the recipients."  

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

0.0
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use